PRESS RELEASE published on 07/01/2024 at 09:22, 1 year 10 months ago Inside Information / Other news releases ABIONYX successfully completes a capital increase of c.€3.4 million through the issuance of shares with warrants. The fundraising aims to strengthen the company's cash position for its development in sepsis and the United States Fundraising Capital Increase Sepsis ABIONYX Shares With Warrants
BRIEF published on 06/27/2024 at 19:27, 1 year 10 months ago ABIONYX Pharma Achieves Unanimous Approval at Combined General Meeting Shareholders Biotech General Meeting Resolutions ABIONYX Pharma
BRIEF published on 06/27/2024 at 19:27, 1 year 10 months ago ABIONYX Pharma obtient l'approbation unanime de l'Assemblée Générale Mixte Actionnaires Assemblée Générale Resolutions Biotechnologies ABIONYX Pharma
PRESS RELEASE published on 06/27/2024 at 19:22, 1 year 10 months ago Inside Information / Other news releases ABIONYX Pharma announces unanimous approval of all resolutions at its Combined General Meeting. Shareholders renew mandates and approve buyback program Shareholders Buyback Program Renewal Combined General Meeting ABIONYX Pharma
PRESS RELEASE published on 06/27/2024 at 19:22, 1 year 10 months ago Informations privilégiées / Autres communiqués ABIONYX Pharma annonce l'approbation unanime des résolutions lors de son Assemblée Générale Mixte. Renouvellement des mandats et programmes approuvés Assemblée Générale Mixte Mandats Renouvelés ABIONYX Pharma Approbation Unanime Programmes Approuvés
BRIEF published on 06/19/2024 at 21:20, 1 year 10 months ago ABIONYX annonce une augmentation de capital sans droit préférentiel de souscription Biotechnologie Actions Augmentation De Capital États-Unis Sepsis
BRIEF published on 06/19/2024 at 21:20, 1 year 10 months ago ABIONYX announces a capital increase without preferential subscription rights Biotechnology Actions United States Increase In Capital Sepsis
PRESS RELEASE published on 06/19/2024 at 21:15, 1 year 10 months ago Informations privilégiées / Autres communiqués ABIONYX annonce une augmentation de capital de 3,4M€ avec suppression du DPS au profit d'une catégorie de personnes, renforçant sa trésorerie pour le développement dans le sepsis et aux États-Unis Augmentation De Capital États-Unis Sepsis ABIONYX Suppression DPS
PRESS RELEASE published on 06/19/2024 at 21:15, 1 year 10 months ago Inside Information / Other news releases ABIONYX announces capital increase of c.€3.4 million with share issuance and warrants, strengthening financial position for Sepsis and US development, supported by ORSAY 53 investment company Capital Increase Share Issuance ABIONYX Sepsis Development ORSAY 53
BRIEF published on 06/13/2024 at 19:53, 1 year 10 months ago ABIONYX Pharma obtient l'aval de la FDA pour une nouvelle étude sur le sepsis FDA Étude Clinique ABIONYX Pharma Sepsis CER-001
Published on 05/09/2026 at 01:30, 1 day 2 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 4 hours ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/09/2026 at 19:05, 9 hours 11 minutes ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 7 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day 9 hours ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day 9 hours ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 2 days 9 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days 9 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 9 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 9 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 9 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
